|
|
2013 Symposium
We would like to thank all of our Speakers, Attendees, and Sponsors for their participation in this event. We feel this was our most successful event yet. Such an impressive turnout of distinguished colleagues from the academic and private sectors, convening to share ideas and discuss opportunities to work more closely together, truly indicates a widepread commitment to closing the gap between the discovery and development of new therapies to help patients.
Photos from the Symposium can be viewed by using the navigation to your left. Coming soon will be Featured Talks from the event! Stay tuned.
Join distinguished investigators and clinicians from academia and top industry representatives in the discussion on the latest breakthroughs and applications in translational oncology. The talks feature important translational oncology discoveries and focus on industry/academia collaboration to overcome the translational gap in cancer drug development. An interactive panel session comprised of industry and academia panelists and a networking reception encourage further dialogue amongst all participants and speakers about collaborative translational oncology projects, driving innovation to better serve patients.
Symposium Organizers and Chairs
Symposium Organizers:
Scott Lippman, MD
Director
UCSD Moores Cancer Center
Ida Deichaite, PhD
Director, Industry Relations
UCSD Moores Cancer Center
|
Symposium Chair:
David Cheresh, PhD
Associate Director for Translational Research
Professor of Pathology
UCSD Moores Cancer Center
Symposium Co-Chair:
Catriona Jamieson, MD, PhD
Director, Stem Cell Research Program
Associate Professor of Medicine
UCSD Moores Cancer Center
|
Symposium Agenda
8:15AM
|
Registration and Continental Breakfast
|
8:50AM
|
Welcome and Overview
|
- Scott Lippman, MD Moores Cancer Center
|
9:10AM
|
- How to Outsmart Cancer
Christian Rommel, PhD, Amgen Inc.
|
9:30AM
|
- From bench to FDA approval at the Moores Cancer Center
Anne Wallace, MD, Moores Cancer Center
|
9:45AM
|
- Mode of action of 2 novel therapeutic antibodies in clinical development: CD44 MAb RG7356 and Her3 MAb RG7116
Klaus Bosslet, PhD, Roche Diagnostics GmbH
|
10:05AM
|
- Part II: The Mouse That ROR’ed – Targeting Onco-Embryonic Antigens
Thomas Kipps, MD, PhD, Moores Cancer Center
|
10:25AM
|
Break
|
10:40AM
|
- Translational Oncology activity of Kyowa Kirin, Discovery and development of CCR4 monoclonal antibody, mogamulizumab
Yukimasa Shiotsu, PhD, Kyowa Hakko Kirin California Inc.
|
11:00AM
|
- Cancer Stem Cell Research: From Bench, to Bedside and Back
Catriona Jamieson, MD, PhD, Moores Cancer Center
|
11:30AM
|
Keynote Presentation
|
- Cancer Treatment with NK Cell Lines: An Effective Alternative?
Armand Keating, MD, FCRP(C), University of Toronto, Princess Margaret Hospital
|
12:00PM
|
Lunch
|
1:15PM
|
- The potential of targeting microRNAs in cancer
Neil Gibson, PhD, Regulus Therapeutics
|
1:30PM
|
- Reversing tumor stemness and drug resistance
David Cheresh, PhD, Moores Cancer Center
|
1:45PM
|
- Translational development of dual TORC1/TORC2 inhibitors and new insight into mechanism of action of the IMiDs
Kristin Hege, MD, Celgene Corporation
|
2:00PM
|
- Carfilzomib: Investigation in Small Cell Lung Cancer (SCLC)
Paula O'Connor, MD, Onyx Pharmaceuticals
|
2:15PM
|
- Role of the Hedgehog Pathway in GIST Stem Cells
Jason Sicklick, MD, Moores Cancer Center
|
2:25PM
|
- Genome-wide Mutational Analysis Reveals Core Signaling Pathways in Mucinous Neoplasms of the Appendix
Olivier Harismendy, PhD, Moores Cancer Center, Rady Children's Hospital
|
2:35PM
|
- Next Generation Sequencing in the Oncology Clinic: The Foundation Medicine Experience
Gary Palmer, MD, JD, Foundation Medicine Inc.
|
2:50PM
|
- Center for Personalized Cancer Therapy: Making Individualized Therapy a Reality
Razelle Kurzrock, MD, Moores Cancer Center
|
3:05PM
|
Break
|
3:30PM
|
Keynote Presentation:
|
- Genomics and Engineering Life
J. Craig Venter, PhD, J. Craig Venter Institute (JCVI), Synthetic Genomics, Inc. (SGI)
|
4:00PM
|
Panel Discussion: Funding translation -- novel partnership models and creative sources of capital
The panel will discuss how to measure the success of innovative partnering models and novel ways to access dollars.
|
- Moderator: Steven Edelson, SciBX:Science-Business eXchange, BioCentury Publications
- Elona Baum, California Institute for Regenerative Medicine (CIRM)
- Ida Deichaite, PhD Moores Cancer Center
- David Kabakoff, PhD, Sofinnova Ventures
- Mark Lappe, Inhibrx
- Arturo Molina, MD, FACP, Janssen Research & Development
- Carl Weissman Accelerator
|
5:00PM
|
Symposium Reception
|
We Thank Our Supporters:
|
